Evidence map›Paper›PMID 35256802›Full record

ArticleNature structural & molecular biology2022

Structural basis of phosphatidylinositol 3-kinase C2α function.

Wen-Ting Lo, Yingyi Zhang, Oscar Vadas, Yvette Roske, Federico Gulluni, Maria Chiara De Santis, Andreja Vujicic Zagar, Heike Stephanowitz, Emilio Hirsch, Fan Liu and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Making PI3K superfamily enzymes run faster.Advances in biological regulation · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. The big chill: Growth ofQRB discovery · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Wen-Ting LoLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany. lo@fmp-berlin.de.ORCID http://orcid.org/0000-0001-7904-6834
Yingyi Zhang *Max Planck Institute for Biophysics, Frankfurt am Main, Germany.
Oscar Vadas *University of Geneva, Faculty of Medicine, Geneva, Switzerland.ORCID http://orcid.org/0000-0003-3511-6479
Yvette RoskeMax Delbrück Centre for Molecular Medicine (MDC), Crystallography, Berlin, Germany.
Federico GulluniDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Maria Chiara De SantisDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.ORCID http://orcid.org/0000-0003-2785-0665
Andreja Vujicic ZagarUniversity of Geneva, Section of Pharmacy, Geneva, Switzerland.
Heike StephanowitzLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.
Emilio HirschDepartment of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
Fan LiuLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.ORCID http://orcid.org/0000-0002-2358-549X
Oliver DaumkeMax Delbrück Centre for Molecular Medicine (MDC), Crystallography, Berlin, Germany.ORCID http://orcid.org/0000-0002-6190-1414
Misha KudryashevMax Planck Institute for Biophysics, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0003-3550-6274
Volker HauckeLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany. haucke@fmp-berlin.de.ORCID http://orcid.org/0000-0003-3119-6993
Leibniz-Forschungsinstitut für Molekulare Pharmakologie · DEUniversity of Turin · ITGoethe University Frankfurt · DEMax Delbrück Center · DEUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphatidylinositol 3-kinase type 2α (PI3KC2α) is an essential member of the structurally unresolved class II PI3K family with crucial functions in lipid signaling, endocytosis, angiogenesis, viral replication, platelet formation and a role in mitosis. The molecular basis of these activities of PI3KC2α is poorly understood. Here, we report high-resolution crystal structures as well as a 4.4-Å cryogenic-electron microscopic (cryo-EM) structure of PI3KC2α in active and inactive conformations. We unravel a coincident mechanism of lipid-induced activation of PI3KC2α at membranes that involves large-scale repositioning of its Ras-binding and lipid-binding distal Phox-homology and C-C2 domains, and can serve as a model for the entire class II PI3K family. Moreover, we describe a PI3KC2α-specific helical bundle domain that underlies its scaffolding function at the mitotic spindle. Our results advance our understanding of PI3K biology and pave the way for the development of specific inhibitors of class II PI3K function with wide applications in biomedicine.

Indexed as

Phosphatidylinositol 3-KinasePhosphatidylinositol 3-KinasesEndocytosisLipidsSignal TransductionLipidsPhosphatidylinositol 3-KinasePhosphatidylinositol 3-Kinases

Identifiers

PMID35256802
PMCPMC8930771
OpenAlexW4220722702

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.